All lobbying filings

PARK STREET STRATEGIES, LLC

PARK STREET STRATEGIES, LLC filed a Q3 report for MASSACHUSETTS BIOTECHNOLOGY COUNCIL on November 10, 2026, reporting $15,000 in lobbying income.

Lobbying for MASSACHUSETTS BIOTECHNOLOGY COUNCIL · Trade association dedicated to advancing research

All filings by PARK STREET STRATEGIES, LLC · Everything MASSACHUSETTS BIOTECHNOLOGY COUNCIL has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Nov 10, 2026

Income

$15,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Monitor health and tax legislation related to biotechnology industry.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.